Interestingly, clonidine, an α2-adrenergic receptor agonist, could ameliorate cognitive deficits and neuronal impairment induced by chronic cerebral hypoperfusion via the upregulation of GABABR1 and GAD67 in the hippocampal CA1. The gene discussed is GABBR1; the disease is Cognitive impairment.